- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Neovacs (ALNEV)
Neovacs stock price live, this page displays EPA ALNEV stock exchange data. View the ALNEV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Neovacs real time stock price chart below.
What Is the Neovacs Stock Price Today?
The Neovacs stock price today is 0.0016.
What Is the Stock Symbol for Neovacs?
The stock symbol for Neovacs is "ALNEV."
What Stock Exchange Does Neovacs Trade On?
Neovacs is listed and trades on the Paris stock exchange.
Is Neovacs a Good Stock to Buy?
Determining whether Neovacs—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALNEV quote. (ISIN: FR0014010856)
What Is the Neovacs Stock Price Today?
The Neovacs stock price today is 0.0016.
What Is the Stock Symbol for Neovacs?
The stock symbol for Neovacs is "ALNEV."
What Stock Exchange Does Neovacs Trade On?
Neovacs is listed and trades on the Paris stock exchange.
Is Neovacs a Good Stock to Buy?
Determining whether Neovacs—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALNEV quote. (ISIN: FR0014010856)
0.0016
-0.0002(-11.11%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0015
0.0018
52 wk Range
0.0015
150.0000
Unusual trading volume
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.00150.0018
52 wk Range
0.0015150.0000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALNEV Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Neovacs Company Profile
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for autoimmune diseases using its Kinoid technology. The company’s product pipeline includes Kinoid, a therapeutic vaccine which allows the immune system to generate natural polyclonal antibodies. IFNa Kinoid, an anti-interferon alpha vaccine which completed Phase I / IIa and IIb clinical trial for the treatment of lupus erythematosus; and Phase IIa clinical trial for the treatment of asthma, dermatomyositis, and all food allergies; and kinoid vaccine that simultaneously targets IL-4 and IL-13 allergies. The company was founded in 1993 and is based in Suresnes, France.
Compare ALNEV to Peers and Sector
Metrics to compare | ALNEV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALNEVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −3.2x | −0.5x | |
PEG Ratio | - | 0.01 | 0.00 | |
Price/Book | 0.0x | 1.8x | 2.6x | |
Price / LTM Sales | 0.0x | 14.0x | 3.3x | |
Upside (Analyst Target) | - | 65.4% | 47.1% | |
Fair Value Upside | Unlock | 4.7% | 5.8% | Unlock |
Earnings
Latest Release
Nov 21, 2025
EPS / Forecast
-5.11 / --
Revenue / Forecast
157.72K / --
People Also Watch
FAQ
What Is the Neovacs (ALNEV) Stock Price Today?
The Neovacs stock price today is 0.0016
What Stock Exchange Does Neovacs Trade On?
Neovacs is listed and trades on the Paris Stock Exchange.
What Is the Stock Symbol for Neovacs?
The stock symbol for Neovacs is "ALNEV."
What Is the Neovacs Market Cap?
As of today, Neovacs market cap is 762.0000.
What Is Neovacs's Earnings Per Share (TTM)?
The Neovacs EPS (TTM) is -9.14.
From a Technical Analysis Perspective, Is ALNEV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Neovacs Stock Split?
Neovacs has split 7 times.
How Many Employees Does Neovacs Have?
Neovacs has 16 employees.
What is the current trading status of Neovacs (ALNEV)?
As of Feb 15, 2026, Neovacs (ALNEV) is trading at a price of 0.0016, with a previous close of 0.0018. The stock has fluctuated within a day range of 0.0015 to 0.0018, while its 52-week range spans from 0.0015 to 150.0000.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.